{"data":{"type":"company_profile","id":175378,"entity_id":"wefunder:company:175378","attributes":{"canonical_url":"https://wefunder.com/sofpulse","generated_at":"2026-06-09T01:21:40Z","updated_at":"2026-06-08T05:01:46Z","entity_ids":{"company":"wefunder:company:175378","slug":"wefunder:company_slug:sofpulse"},"profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-09T01:21:40Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-08T05:01:46Z","as_of":"2026-06-09T01:21:40Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-08T05:01:46Z","as_of":"2026-06-09T01:21:40Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2026-05-01T05:08:17Z","as_of":"2026-06-09T01:21:40Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2026-05-01T05:08:17Z","as_of":"2026-06-09T01:21:40Z","confidence":"medium"}}},"company":{"id":175378,"entity_id":"wefunder:company:175378","slug":"sofpulse","name":"SofPulse, Inc.","tagline":"Conquer Pain, End Addiction","story":"SofPulse® offers an FDA-cleared medical device that reduces post-operative pain, inflammation and edema cutting opioid use up to 70%.With 50 million surgical patients yearly in the US, an additional 15 million Veterans and millions of Americans retiring to Elder Care and Assisted living facilities yearly (where 1 out of 10 is at risk of bedsores or chronic wounds yearly), SofPulse® is in the position to make major difference in drug-free pain management and speeding up recovery. With plans to secure Insurance medical reimbursement, SofPulse® aims to become the standard of care for reducing opioid use, accelerating recovery and reducing healthcare costs which will help us save lives.Join us to help fight the opioid crisis. Invest now and be part of the solution!Goal: Raise funds to achieve insurance medical reimbursement for SofPulse® FDA-cleared device, enabling widespread adoption in the US surgical markets, VA/DoD and the aging U.S. Eldercare markets so we can significantly reduce opioid use and dependency for pain relief.Future projections are not guaranteed.The opioid crisis has been ravaging communities and families across the United States for the past decade.More than 560,000 people in the United States have died from overdoses involving opioids since the epidemic began; The number of annual opioid overdose deaths remains more than 8 times higher than it was in 1999; There were approximately 80,000 overdose deaths in 2024.SofPulse is stepping up to tackle this monumental challenge in the healthcare marketThe Opioid Crisis:According to the National Center for Drug Abuse (NCDAS) Opioids are the deadliest drug type:· 4 out of 5 people using heroin first misused prescription Opioids.· At least one type of opioid is a factor in 7 out of 10 Overdose deaths.· Overdose deaths rank just below diabetes in terms of highest death count.· Killing more than 230 Americans every day.· Drug overdoses have killed almost a million people since 1999.It is clear that we need safer, effective alternatives for opioids as well as finding ways to reduce their use.SofPulse® technology effectively alleviates pain associated with surgical procedures and chronic inflammatory conditions, reducing the need for opioid medications. By providing safe and effective pain management, we aim to minimize the risks associated with opioid use, including dependency and adverse side effects.In postoperative care, SofPulse® devices not only enhances recovery but also works to prevent possible escalation into opioid dependency.The VHA and DoD are presently evaluating SofPulse® devices as a solution for reducing opioid use in post-surgical pain, wound management and breakthrough pain experienced prior to surgery. SofPulse®’s inclusion in the Federal Supply Schedule opens doors to the largest integrated healthcare system in the US. Our heroes often face challenges with pain and recovery, making them key beneficiaries of the SofPulse® solution.SofPulse has quickly established itself as a leader in the emerging medical device space, delivering innovative, and non-invasive treatments that address pressing needs in patient care.Our FDA-cleared medical device for postoperative reduction in pain and edema as well as in the promotion of wound recovery provides effective palliative care, particularly for vulnerable populations such as the elderly and those with limited mobility.SofPulse® medical devices have 18 granted patents for treating pain and inflammation related conditions including: Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Inflammation, Strokes and other related conditions with PEMF (Pulsed Electromagnetic Frequency) therapy.SofPulse is the only therapeutic option to treat pain after surgery other than a NSAID which is far less effective. The superior effects, we believe, enable this technology to be the \"go to pain\" management option upon receiving Medical Reimbursement - we believe this will change the world and enables our supporters to see a geometric return!FDA cleared for its adjunctive use in reduction and treatment of postoperative pain and edema, SofPulse® has shown clinical efficacy in postoperative use to have a 3X reduction of pain mean scores, 275% reduction in postoperative inflammation and edema, and a 2.2-fold reduction in the need for pain medication compared to placebo treatments - without known side effects or contraindications.Additionally, an investigator-initiated study, authored by Dr. Samir Awad, Professor of Surgery at Baylor College of Medicine, entitled ‘The Impact of Pulsed Electromagnetic Field (SofPulse®) on Postoperative Pain in Patients Undergoing Cardiothoracic Surgery’ demonstrate that the use of SofPulse® significantly decreased postoperative pain by 50%, decreased opioid requirements by 70%, and resulted in a significant decrease in Length of Stay at the hospital by a median of 2 days.SofPulse® currently stands as the only viable non-invasive, FDA-cleared product on the market that effectively reduces pain, edema, and inflammation while treating and preventing pressure ulcers.The device has previously received CMS National Coverage for managing chronic wounds, reinforcing its clinical significance and providing reimbursement opportunities for healthcare providers.Upon us completing a multi-site definitive trial to obtain Medical Reimbursement and bring SofPulse® to market, we expect Geometric Growth and Profit..It is that simple; 50 million patients each year have surgical procedures and needing our device for a better result. 50 million x $500 is a total available market of $25 billion!Future projections are not guaranteed.Future projections are not guaranteed.Future projections are not guaranteed.Initial Raise:Upon completing the audited financials for 2023 and 2024, we plan to file an amendment to increase the raise to $5,000,000.We plan to file an S-1 with the SEC to register your shares and take the company public. Our goal is to become a NASDAQ or NYSE listed company shortly thereafter.Future projections are not guaranteed.Why Invest in SofPulse?And You Can Get Perks:Together, We Can Get SofPulse® Medical Reimbursement and Help Millions of PeopleBy investing in SofPulse, you're helping us reduce the opioid consumption after surgery for all surgical patients. Let’s prevent addiction by making SofPulse® the standard of care in every Hospital stay and save lives daily.We can:Help society fix a horrible problem – Opioid Addiction! Provide our investors an opportunity to make a substantial profit on their investment.So let's help people consume less opioids!Please join us in making this a reality.","location":"Fuquay Varina, NC","website":"https://www.sofpulse.com","total_amount_raised":130395,"total_investors":177,"is_funded":true,"is_active":true,"quality_score":3,"related_urls":["https://wefunder.com/sofpulse","https://www.sofpulse.com"]},"media":{"share_image_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/175378/xxl_blob.jpg","logo_url":"https://uploads.wefunder.com/uploads/company/logo/175378/large_blob.jpeg","header_media_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/175378/standard_blob.jpg","cover_photo_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/175378/standard_blob.jpg"},"links":{"company_url":"https://www.sofpulse.com","facebook_url":"https://facebook.com/sofpulse","instagram_url":"https://instagram.com/sofpulseteam"},"highlights":[{"id":62736,"name":"notable_angel","url":"notableangel","presentable_name":"Notable Angel","description":"Raised $25k or more from a notable angel investor","image_url":"https://uploads.wefunder.com/2021/profile-highlights-check.svg"},{"id":75537,"name":"repeat_founder","url":"repeatfounder","presentable_name":"Repeat Founder","description":"Started a prior company with $2M+ in funding or revenue","image_url":"https://uploads.wefunder.com/2021/profile-highlights-replay.svg"}],"quick_facts":[{"index":1,"claim_id":"claim-fact-1","value":"FDA-Cleared for Postoperative Pain and Edema \u0026amp; Listed on the Fed Supply System for sales to VA/DoD"},{"index":2,"claim_id":"claim-fact-2","value":"50 million post-operative patients in the U.S. Hospital Market - Total Available Market: $25 Billion"},{"index":3,"claim_id":"claim-fact-3","value":"Robust Patent Portfolio: 18 Granted Patents Related to PEMF Therapies Including TBI, MS \u0026amp; Strokes"},{"index":4,"claim_id":"claim-fact-4","value":"Proj. Rev from US Hospital Market after receiving Medical Reimbursement: $1.25B/Yr (not guaranteed)"},{"index":5,"claim_id":"claim-fact-5","value":"Drug-free Solution for Eldercare/Assisted Living Facilities: Proj. Rev. 2026: $8.7M (not guaranteed)"},{"index":6,"claim_id":"claim-fact-6","value":"Received CE Mark: Expanding into Asia, Europe \u0026amp; South American Healthcare Markets"},{"index":7,"claim_id":"claim-fact-7","value":"Obtained Taiwan-FDA Approval and signed Exclusive Distributorship for $21mm in revenue over 6 years."},{"index":8,"claim_id":"claim-fact-8","value":"Preparing to go public: filing a S-1 to register the CF Shares (not guaranteed)"}],"team":[{"id":5505898,"entity_id":"wefunder:company_role:5505898","user_entity_id":"wefunder:user:4667284","role":"founder","name":"Alan Collier","title":"CEO","bio":"With over 30 years experience specializing in the development and financing of early stage and acquisitive companies. Mr. Collier was previously a managing director of two registered investment banks and has taken multiple companies public in the US.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5505898/square_blob.jpg?1775153740","profile_url":"https://wefunder.com/alan.collier","related_urls":["https://wefunder.com/alan.collier"]},{"id":5550459,"entity_id":"wefunder:company_role:5550459","role":"employee","name":"David Irving","title":"Chief Communications Officer","bio":"Mr. Irving, former NFL defensive tackle turned advocate to reduce opioid dependency and for treatments of Traumatic Brain Injury, describes SofPulse® as the only effective treatment for his conditions. His goal is to help it become the standard of care...","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5550459/square_blob.jpg?1775153740","related_urls":[]},{"id":5506772,"entity_id":"wefunder:company_role:5506772","role":"founder","name":"Ira Weisberg","title":"President","bio":"Mr. Weisberg has extensive executive experience in healthcare with executive positions at Alphavax, Inc., Lifecycle Pharma, Chugai Pharma USA, Haemac He negotiated out-licensing agreements with major pharmaceutical companies in excess of $100 million.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5506772/square_blob.jpg?1775153740","related_urls":[]},{"id":5506790,"entity_id":"wefunder:company_role:5506790","role":"employee","name":"Andre' DiMino","title":"Regulatory Consultant","bio":"Mr. Dimino has extensive engineering and science background in the design, development, commercialization and manufacturing of medical devices. He has over 30 years of experience in FDA and international regulatory requirements for medical products.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5506790/square_blob.jpg?1775153740","related_urls":[]},{"id":5513334,"entity_id":"wefunder:company_role:5513334","role":"founder","name":"Steven Barnes","title":"Senior Vice President","bio":"Mr. Barnes has over 25 years of corporate finance experience and has structured numerous private and public debt and equity offerings in many sectors including biotechnology, healthcare, companies.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5513334/square_blob.jpg?1775153740","related_urls":[]},{"id":5725821,"entity_id":"wefunder:company_role:5725821","user_entity_id":"wefunder:user:4794171","role":"employee","name":"Carmen Naidoo","title":"Creative Content Manager ","bio":"Miss Naidoo is a seasoned creative strategist with over 10 years of experience leading brand, pitch, and communications work for startups, churches and nonprofits. She's built digital awareness campaigns for innovative companies across multiple sectors.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5725821/square_blob.jpg?1775153740","profile_url":"https://wefunder.com/carmen.naidoo","personal_url":"https://www.sofpulse.com","related_urls":["https://wefunder.com/carmen.naidoo","https://www.sofpulse.com"]}],"featured_investors":[{"id":11822,"entity_id":"wefunder:company_investor_profile:11822","investor_profile_id":4284136,"investor_profile_entity_id":"wefunder:investor_profile:4284136","subject_entity_id":"wefunder:notable_investor:15619","name":"Harry Feinberg","role_title":"","avatar_url":"https://uploads.wefunder.com/2021/user_default_icon_circle.png","profile_url":"https://wefunder.com/harry.feinberg","endorsement_quote":"I invested for two reasons: because of the CEO/director, Alan Collier, and because of SofPulse's technology. It's incredible. This device is amazing in how it treats pain, wound care, gets people out of the hospital quicker and keeps people off pills. The electromagnetic frequency (\"PEMF\") technology is a clinically proven substantial factor in healing. I have been a lawyer in Philadelphia for the last 25 years. I stand by this company and its directors fully or I never would have invested a large sum. I believe a company is only as strong as its management, so that was a crucial factor in why I invested. The future is bright for this company, especially now that we need to certainly pivot away from pills. The device helps heal wound and surgical issues at such a rapid pace that it is an incredibly attractive option for consumer/hospitals/elder care facilities. Based on this proven technology, I do feel this is the future for wound care.\" Harry Feinberg","endorsement_name":"","is_lead_investor":false,"memo_paid_for_by_company":false,"related_urls":["https://wefunder.com/harry.feinberg"]},{"id":11829,"entity_id":"wefunder:company_investor_profile:11829","investor_profile_id":4220948,"investor_profile_entity_id":"wefunder:investor_profile:4220948","subject_entity_id":"wefunder:user:4729961","name":"K Tucker Andersen","role_title":"","bio":"B.A. Quantitative Studies Wesleyan University CFA, ASA, formerly co-managing partner $1B+ fundamentally oriented long biased hedge fund, previously trustee of two private educational institutions , completing - 36th year as member of Philips Exeter IC","avatar_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6NTYwNjkwLCJwdXIiOiJibG9iX2lkIn19--45487dfd0d967f455b4f50cc1474091df2d127bf/filename","profile_url":"https://wefunder.com/k.tucker.andersen.1","endorsement_quote":"During the last few years I have followed the progress of the company in the development of SofPulse and gotten to know and trust management. The opioid crisis has exacted a huge financial and personal toll on our country and the families impacted. I am extremely excited about the potential of SofPulse to help solve the opioid crisis by providing drug free pain treatment for millions of individuals. This is a wonderful example of the type of investment which I attempt to find - a company with a product that can do a great deal of good while at the same time potentially providing the investor a chance for their investment to do well.","endorsement_name":"","investment_total":681000,"investment_info":"Invested $5,000 this round \u0026 $676,000 previously","is_lead_investor":true,"memo_paid_for_by_company":false,"related_urls":["https://wefunder.com/k.tucker.andersen.1"]}],"investor_memos":[],"tab_counts":{"posts":0,"ask_questions":9,"featured_investors":2,"faq_entries":5},"active_fundraises":[{"id":135228,"entity_id":"wefunder:fundraise:135228","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"ttw","security_type":"","currency":"USD","testing_the_waters":true,"min_purchase":100,"max_purchase":9,"funding_target":1235000.0,"minimum_target":"50000.0","maximum_target":"1235000.0"},{"id":135227,"entity_id":"wefunder:fundraise:135227","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"equity","security_type":"equity","currency":"USD","testing_the_waters":false,"min_purchase":100,"max_purchase":9,"funding_target":1235000.0,"minimum_target":"50000.0","maximum_target":"1235000.0","funding_started_at":"2025-09-26T00:35:40Z","funding_closed_at":"2026-05-01T03:59:59Z","auto_close_at":"2026-05-01T03:59:59Z"}],"latest_fundraise":{"id":135228,"entity_id":"wefunder:fundraise:135228","state":"successful","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":false,"funding_started_at":null,"funding_closed_at":null,"terms":{"eb":"$92.5M","nb":"$102.9M","txt":"pre-money valuation"}},"recent_posts":[],"q_and_a":[{"id":320019,"entity_id":"wefunder:comment:320019","question":"Follow up question on this FAQ: “What clinical \u0026amp; preclinical studies are available for SofPulse®? In multiple trials, the use of SofPulse® has resulted in significant reductions in pain and use of narcotics.”… COULD YOU PLEASE SHARE A LINK (that actually works) TO THESE STUDIES?","author_name":"Dr. Paul Adjei","votes":1,"created_at":"2025-11-20T23:35:50Z","canonical_url":"https://wefunder.com/sofpulse#question-320019","answers":[{"id":320077,"entity_id":"wefunder:comment:320077","answer":"Please see our Clinical Research Library at: https://www.sofpulse.com/research-library and the studies at: https://www.clinicaltrials.gov/search?term=sofpulse. If you are a medical doctor and want to use it in post op pain management, please email me at: acollier@sofpulseinc.com we can get you a demo unit for evaluation purposes. Sincerely, Alan Collier, CEO","author_name":"Alan Collier","votes":0,"created_at":"2025-11-22T18:42:16Z"}]},{"id":315941,"entity_id":"wefunder:comment:315941","question":"What is your reimbursement strategy, will you submit for a Level I CPT code or a Level III HCPS code as DME? You have stated that use of the device would be covered under the DRG for an inpatient stay. Have you performed any cost benefit studies compared to opioids? Do you expect to market the device for outpatient surgery?","author_name":"Jim Garver","votes":1,"created_at":"2025-09-29T20:57:58Z","canonical_url":"https://wefunder.com/sofpulse#question-315941","answers":[{"id":316280,"entity_id":"wefunder:comment:316280","answer":"Hi Jim, SofPulse Inc, will be pursuing an HCPCS code for reimbursement rather than CPT Level I coding, as the device is a product used adjunctively in surgical care rather than a physician procedure. We have completed several internal cost benefit evaluations with SofPulse® vs traditionally accepted treatments to show significant impact on reducing costs and savings for patients, hospitals and insurance carriers. Our dual-path for medical insurance and hospital reimbursement includes: 1)HCPCS code for outpatient billing and other outpatient applications, and 2) inclusion to hospital surgical DRGs as a standard adjunctive device for reduction of post-operative pain and edema management.* The clinical data supports inclusion in DRG bundled payments as a drug-free, opioid reducing treatment that has shown to decrease overall costs for surgery. If you have any additional questions, please feel free to contact me at: acollier@sofpulseinc.com. Sincerely, Alan Collier, CEO","author_name":"Alan Collier","votes":0,"created_at":"2025-10-03T21:43:38Z"}]},{"id":315830,"entity_id":"wefunder:comment:315830","question":"Is it approved my Medicare?","author_name":"Jim Hall","votes":1,"created_at":"2025-09-26T15:22:31Z","canonical_url":"https://wefunder.com/sofpulse#question-315830","answers":[{"id":315849,"entity_id":"wefunder:comment:315849","answer":"Not yet. Our Company is seeking Medicare and other third-party insurance reimbursement. As part of this effort, we are working with the clinical staff of the UCSD system to conduct a blinded and controlled clinical trial to conclusively demonstrate the safety and efficacy of SofPulse®. This data will be provided to the reimbursement panels at Medicare and the other companies once completed.","author_name":"Alan Collier","votes":2,"created_at":"2025-09-26T23:09:21Z"},{"id":316279,"entity_id":"wefunder:comment:316279","answer":"HI Jim, SofPulse Inc, will be pursuing an HCPCS code for reimbursement rather than CPT Level I coding, as the device is a product used adjunctively in surgical care rather than a physician procedure. We have completed several internal cost benefit evaluations with SofPulse® vs traditionally accepted treatments to show significant impact on reducing costs and savings for patients, hospitals and insurance carriers. Our dual-path for medical insurance and hospital reimbursement includes: 1)HCPCS code for outpatient billing and other outpatient applications, and 2) inclusion to hospital surgical DRGs as a standard adjunctive device for reduction of post-operative pain and edema management.* The clinical data supports inclusion in DRG bundled payments as a drug-free, opioid reducing treatment that has shown to decrease overall costs for surgery. If you have any additional questions, please feel free to contact me at: acollier@sofpulseinc.com. Sincerely, Alan Collier, CEO","author_name":"Alan Collier","votes":0,"created_at":"2025-10-03T21:40:50Z"}]},{"id":315829,"entity_id":"wefunder:comment:315829","question":"How much does it cost?","author_name":"Jim Hall","votes":1,"created_at":"2025-09-26T15:18:51Z","canonical_url":"https://wefunder.com/sofpulse#question-315829","answers":[{"id":315848,"entity_id":"wefunder:comment:315848","answer":"Hi Jim, SofPulse® is available through physician prescriptions to the public at a current unit price of $500. SofPulse® is the only effective PEMF non-opioid alternative medical device cleared by the FDA for the treatment of postoperative pain and edema. In thousands of patient uses, no adverse effects have been reported. If you have any additional questions, please feel free to contact me at: acollier@sofpulseinc.com. Sincerely, Alan Collier, CEO","author_name":"Alan Collier","votes":0,"created_at":"2025-09-26T22:59:49Z"}]},{"id":314061,"entity_id":"wefunder:comment:314061","question":"But how does it work exactly? What method, applied to skin, how and where? Exact details that make it work and how its effective. Lots of info, but nothing on actual details give any potential customer or investor why it works, answering this important question may help you raise more money, faster. Ted Southern Cal.","author_name":"Ted Thomas","votes":1,"created_at":"2025-08-31T18:42:04Z","canonical_url":"https://wefunder.com/sofpulse#question-314061","answers":[{"id":314313,"entity_id":"wefunder:comment:314313","answer":"Hi Ted, Below are our frequently asked questions. If you have any other questions please email me directly at: acollier@sofpulseinc.com Sincerely, Alan Coliier, CEO SofPulse® Frequently Asked Questions: 1. What is SofPulse®? SofPulse® is a unique technology that utilizes targeted pulsed electromagnetic fields (tPEMF) therapy and is cleared by the FDA to treat pain and edema resulting from operative procedures. The SofPulse® device is simple, automated and easy to use. It has a compact design with a flexible applicator and is battery operated; 2. What is the FDA status of SofPulse®? SofPulse® is cleared by the FDA as a Class II medical device; 3. What is SofPulse® indicated for? SofPulse® is indicated for adjunctive use in palliative treatment of postoperative pain and edema in superficial soft tissue; 4. When should SofPulse® not be used? The contraindications include patients with implanted electrical leads, like pacemakers, deep brain simulators and similar technology. SofPulse® has not been tested in pregnant or lactating women or children; 5. What are the benefits of SofPulse®? SofPulse® has demonstrated outstanding clinical results, with significant reductions in postoperative opioid use, pain, and edema: • 2.2X reduction in the use of narcotics at 48 hours • 300% reduction in mean pain scores at 5 hours • 275% reduction in inflammation and swelling at 18 hours; 6. How does SofPulse® work? SofPulse® delivers targeted pulsed electromagnetic field (tPEMF) therapy by emitting gentle electric pulses of a very low level non-invasively into cells. Through these pulses, SofPulse® creates an electromagnetic field which evenly penetrates both soft and hard body tissue around the target area. This electromagnetic field causes a chemical cascade, which activates the Nitric Oxide cycle. Nitric Oxide (NO), a key anti-inflammatory and cellular pathway, increases blood and lymph flow thereby reducing pain and edema; 7. What is the treatment area/depth of the SofPulse® therapy? The treatment area of SofPulse® includes the area within the applicator ring (7.5” diameter) and approximately 5 inches deep; 8. How long is a treatment duration with SofPulse®? The SofPulse® treatment duration is 15 minutes; 9. How many treatments will my patient receive with one SofPulse® device? Each SofPulse® unit provides 100 +/- treatments. Using the preprogrammed mode, SofPulse® automatically delivers 15 minutes of therapy every two hours, providing 8 days of continuous therapy; 10. What clinical \u0026amp; preclinical studies are available for SofPulse®? In multiple trials, the use of SofPulse® has resulted in significant reductions in pain and use of narcotics; 11. Are SofPulse® micro-currents safe? The SofPulse® micro-current levels are extremely low. To put it in perspective, SofPulse® emits an electromagnetic field that has 1,000 times LESS peak power than a mobile phone. The SofPulse® device has been manufactured and tested in accordance with IEC 60601-1, 60601- 1-2, and 60601-2-3. SofPulse® is non-pharmacologic with no potential for overdose or dependency and is noninvasive and safe for use with other pain treatments; 12. Will the patient feel anything while SofPulse® is working? In general, most patients will not feel anything while using SofPulse®. Patients with reduced blood flow peripherally may report warming or tingling in the area of treatment. Similarly, reports of tingling and other sensations have been reported in patients with neuropathies. These sensations are normal and can be increased blood flow; 13. How soon will the patient feel results using SofPulse®? In acute injury, like surgical incisions, the effect of SofPulse® on pain reduction is felt very quickly, typically in the first day; 14. Are there any side-effects of using SofPulse®? Unlike prescription drugs or narcotic painkillers, no side effects have been reported with the use of SofPulse®. While unlikely, since SofPulse® therapy increases circulation; some patients may feel a subtle warming or tingling sensation. With SofPulse® therapy, the body does not respond to the low energy signal unless there is inflamed tissue so there is no risk of side effects; 15. Will the patient need to take pain medication when utilizing SofPulse®? SofPulse® is an adjunctive therapy. Pain medication should be allowed as per the standard of care. Patients generally decide at some point how and when to use pain medication. SofPulse® has been shown to decrease pain medication use significantly post-surgically and each patient will determine how much pain medication they need; 16. Is the SofPulse® device supplied sterile? No. The SofPulse® device is intended to be used over sterile dressing and should not come in direct contact with the surgical wound; 17. Can more than one SofPulse® unit be used at the same time on one patient? Yes. Multiple units can be used but should not overlap nor be used in opposition (one on top and one on the bottom of a knee); 18. How should SofPulse® be applied? SofPulse® should be applied with its circular geometry intact as well as possible in the treatment area within the same plane as the applicator loop. It is possible to loop the unit around the affected area (thus in the perpendicular plane) when appropriate. Tape or otherwise secure the SofPulse® applicator loop over the dressing of the desired treatment area. SofPulse® is designed to be worn continuously during the 8-day treatment period but may be removed for short periods of time for dressing changes or washing, after which, it should be re-secured to the body. Do not get SofPulse® wet. SofPulse® can also be affixed to any orthopedic brace, wrap, sling, or splint and is effective through dressings, casts, and clothes, but should not be used over external metal items such as metal braces; 19. Can SofPulse® be utilized in procedures with metal implants (hip, knee, shoulder, spine)? SofPulse® can be used after joint replacement and spine procedures using metal implants; 20. Can SofPulse® be placed in direct contact with the patient? SofPulse® is not intended to be placed on bare skin to avoid pressure and/or friction against the skin. The SofPulse® electromagnetic field penetrates unimpeded through non-metallic dressings, clothing and casting material; 21. Will bending the SofPulse® applicator ring hurt the unit? Distorting the circular treatment antenna will deform the treatment field. In moderate displacement the SofPulse® will function, but folding the unit beyond 30 degrees or pulling the loop into an extreme elliptical form can lead to significant distortion and reduction of the treatment field; 22. Can SofPulse® be secured underneath the patient, can they lie on it? Any configuration generating friction or pressure against the skin should be avoided; 23. Is SofPulse® safe to use around my face and head? There are no restrictions on areas of the body. SofPulse® has been used on post-facial procedures. Research on treating brain injuries has also been conducted without any adverse events nor known side effects; 24. Can SofPulse® be utilized in patients with Left Ventricular Assist Device (LVAD) systems? LVAD systems generally use an electromagnetic field (EMF) based pump and there is a potential for the SofPulse® to interfere with the pump. Use with EMF dependent pumps should be avoided; 25. Can SofPulse® be utilized in patients receiving oxygen after surgery? SofPulse® is safe for use in most environments except oxygen enriched environments such as hyperbaric oxygen treatment; 26. How do I operate SofPulse®? Once powered on, SofPulse® will operate automatically turning itself on and off on its own schedule (automatic treatment mode). When in this mode, treatments last for 15 minutes every two hours. • During active treatment -- 2 therapy indicator lights will blink every 1 second. • In between treatments -- 1 therapy indicator light will blink approximately every 6 seconds indicating the device is in stand-by mode; To turn the device off, press the power button. The SofPulse® is off when the indicator lights do not flash. When the device is turned on again, it will begin a new 15-minute active treatment. If you do not stop the treatment, the SofPulse® will go back into stand-by mode after 15 minutes and will continue in automatic mode (15 minute treatments every 2 hours); 27. Will SofPulse® permanently damage equipment such as TV and radio? Properly shielded consumer electronics should not be affected permanently by the SofPulse® device. Some older technologies may have intermittent interference; 28. What is the difference between SofPulse® and TENs units? TENS units use direct electrical current to generate action potentials in nerves to mask pain or contract muscles. SofPulse® is vastly lower powered and does not cause action potentials to be generated nor does it produce electrical currents. SofPulse® generates an electrical field that improves electrochemical activity in the constitutive nitric oxide synthase (cNOS) pathways; 29. How is SofPulse® different from other non-opioid post-op pain reduction options? SofPulse® is a nonpharmacologic pain solution clinically proven to reduce postoperative pain and edema. Exparel®, On-Q® and Ofirmev® are only indicated to reduce postoperative pain, not edema; With up to 8 days of treatments, SofPulse® may provide significant cost-savings per procedure compared to other postoperative pain options; 30. Can SofPulse® be used in conjunction with application of cold therapy? Ice and cold therapies can reduce the effectiveness of the SofPulse® device because they reduce blood flow. We advise using the SofPulse® before ice application or after the cooling effect has worn off; 31. Can the SofPulse® batteries be replaced? No, due to the medical device regulations, the SofPulse® case must be sealed. Breaking the case seal for any reason renders the device non-compliant with the conditions of its 510(k) clearance; 32. How will my patient know the SofPulse® unit is working? SofPulse® does not make sound while working. Please refer to the indicator lights: • During active treatment -- 2 therapy indicator lights will blink every 1 second. • In between treatments -- 1 therapy indicator light will blink approximately every 6 seconds indicating the device is in stand-by mode; 33. What instructions should be given to the patient regarding their SofPulse® unit? The SofPulse® IFU and manual contain all appropriate information on use. Other available SofPulse® patient tools include: • SofPulse® Patient Brochure • SofPulse® User Guide • SofPulse® Fitting Checklist • SofPulse® Treatment Protocol; 34. What should my patient do with the SofPulse® unit after my treatment is finished? SofPulse® is an electronic device containing lithium batteries. Please consult your local and state regulations for proper disposal of a product of this type; 35. How is SofPulse® reimbursed? SofPulse® presently has no insurance coverage. SofPulse® when adopted by hospitals, is covered by the hospital under the DRG for that specific hospital. Reimbursement for SofPulse® when not covered by hospital DRG, is through direct patient payment to cover SofPulse® use and application; 36. How can I order or set up an evaluation for SofPulse®? Please email orders to: orders@sofpulse.com; and 39. Is SofPulse® available to non-medical public? SofPulse® is currently only available for prescription use. 1. Heden P., et al. Effects of pulsed electromagnetic fields on postoperative pain: A double blind randomized pilot study in breast augmentation patients. Aesthetic Surgery Journal. 2008. 2. Rohde C., et al. Effects of pulsed electromagnetic fields on Interleukin-1 and postoperative pain: A double blind, placebo controlled, pilot study in breast reduction patients. Plastic and Reconstructive Surgery Journal. 2010. 3. Johnson M., et al. Standard pain and edema model showing significant effects on pain and edema. BEMS. 2008. 4. Strauch B., et al. Pulsed magnetic field therapy increases tensile strength in a rat achilles’ tendon repair model. Journal of Hand Surgery. 2006. 5. Nelson F., et al. The use of a specific pulsed electromagnetic field (PEMF) in treating early knee osteoarthritis. Orthopedic Research Society. 2010. References • Effects of Pulsed Electromagnetic Fields on Postoperative Pain: A Double-Blind Randomized Pilot Study in Breast Augmentation Patients Hede P, Pilla A Aesth Plast Surg (2008) 32:660–666 DOI 10.1007/s00266-008-9169-z • Pulsed Electromagnetic Fields Reduce Postoperative Interleukin-1β, Pain, and Inflammation: A Double- Blind, Placebo-Controlled Study in TRAM Flap Breast Reconstruction Patients Rohde C, Pilla A. et al. Breast, Volume 135, Number 5 • Effect of Pulsed Electromagnetic Fields • SofPulse Electroceutical™ Therapy [User Manual]. Endonovo Therapeutics. 12. Pilla AA. (1999) State of the art in electromagnetic therapeutics: soft tissue applications. 871-874. • Exparel [Prescribing Information]. Pacira Pharmaceuticals, Inc. • On-Q Pain Relief System [Instructions for Use]. Halyard Health, Inc. • Ofirmev [Prescribing Information]. Mallinckrodt Pharmaceuticals • Mont MA, Beaver WB, Dysart SH, Barrington JW, Del Gaizo DJ. Local Infiltration Analgesia With Liposomal Bupivacaine Improves Pain Scores and Reduces Opioid Use After Total Knee Arthroplasty: Results of a Randomized Controlled Trial. J Arthoplasty. 2018;33(1):90-96. • Wininger SJ, Miller H, Minkowitz HS, et al. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery. Clin Ther. 2010;32(14)2348-69. SofPulse® is a registered trademark of SofPulse, Inc. The trademarks of the products listed herein are trademarks of their respective manufacturer. Please refer to the Instructions for Use accompanying each device for further information.","author_name":"Alan Collier","votes":1,"created_at":"2025-09-03T21:01:48Z"},{"id":314315,"entity_id":"wefunder:comment:314315","answer":"Hi Ted, Realize that the way that the response came through was without paragraph breaks. Please send me your email address and I will forward a PDF copy to you. Alan","author_name":"Alan Collier","votes":0,"created_at":"2025-09-03T21:06:50Z"}]},{"id":313604,"entity_id":"wefunder:comment:313604","question":"Hi Alan, would you please provide some additional details on your \"Robust Patent Portfolio\"? How many are granted, and in which countries, and do you also have ones pending? Do you foresee additional submissions? Thanks. Blessings","author_name":"W Kim Colich","votes":1,"created_at":"2025-08-25T04:41:42Z","canonical_url":"https://wefunder.com/sofpulse#question-313604","answers":[{"id":313780,"entity_id":"wefunder:comment:313780","answer":"Hi Kim, “Our \"Robust Patent Portfolio”, the SofPulse® patent portfolio, consists of 18 granted patents in the US, Europe and several Asian markets in addition to 10 US trademarks. These patents cover the basic Pulsed Electromagnetic Field (\"PEMF\") technologies as well as use patents describing the use of SofPulse® in various therapeutic applications such as pain, Alzheimer’s, multiple sclerosis and other neurological uses. We have several new patent applications pending submission over the next several years intended to expand the use of SofPulse® in other therapeutic applications. Please feel free to contact me at: acollier@sofpulseinc.com if you have any additional questions. Sincerely, Alan Collier, CEO","author_name":"Alan Collier","votes":0,"created_at":"2025-08-26T19:21:07Z"}]},{"id":313584,"entity_id":"wefunder:comment:313584","question":"While the obvious benefits of post-operative pain reduction are wonderful, I'm wondering from a business point of view if a much. much larger target market in the future wouldn't be replacing meds as a solution for atherosclerotic inflammation and metaflammation---Jeff Bezos might be wondering if he has enough cash on hand to buy you out if that's the case","author_name":"Jerry Irwin","votes":1,"created_at":"2025-08-24T05:02:51Z","canonical_url":"https://wefunder.com/sofpulse#question-313584","answers":[{"id":313805,"entity_id":"wefunder:comment:313805","answer":"HI Jerry, Inflammation affects everything. Inflammation can cause cell death and organ failure if not treated and Metabolic inflammation, also known as metainflammation, is a key component in the progression of Non-Alcoholic Fatty Liver Disease (NAFLD) to Nonalcoholic Steatohepatitis (NASH). Because SofPulse® has proven clinical studies that show SofPulse® has effectively reduced inflammation after post-operative procedures, both preclinical and predicate studies have been performed in several indications including NASH to determine additional medical indications for SofPulse®. A preclinical study on mice with NASH related liver injury was performed using SofPulse® to determine if SofPulse® could counteract the effects of Nonalcoholic Steatohepatitis (NASH) in an animal model. They found in one to two weeks of treatment with Sofpulse® that SofPulse® appeared to counteract several of the disease signs associated with NASH-associated liver damage. For more information, please reach out to me directly at: acollier@sofpulseinc.com. Sincerely, Alan Collier, CEO","author_name":"Alan Collier","votes":1,"created_at":"2025-08-26T23:21:51Z"}]},{"id":313473,"entity_id":"wefunder:comment:313473","question":"I read the lengthy introduction and promotion of the product.However I really could not find prominent photos and serious explanations of how it looks and works.","author_name":"Bruce LaPlante","votes":1,"created_at":"2025-08-21T19:14:37Z","canonical_url":"https://wefunder.com/sofpulse#question-313473","answers":[{"id":313475,"entity_id":"wefunder:comment:313475","answer":"Hi Bruce, Please review our product site at SofPulse.com. Feel free to contact me directly at acollier@sofpulseinc.com with any questions... Thank you for your interest. Sincerely, Alan Collier, CEO","author_name":"Alan Collier","votes":0,"created_at":"2025-08-21T19:20:00Z"}]},{"id":311850,"entity_id":"wefunder:comment:311850","question":"What is the FSS Contract number or the SIN number so I can look up SofPulse in the MedSurg catalog? Thanks!","author_name":"Erick Schultz","votes":1,"created_at":"2025-07-24T19:11:14Z","canonical_url":"https://wefunder.com/sofpulse#question-311850","answers":[{"id":311921,"entity_id":"wefunder:comment:311921","answer":"Hi Erick, The SIN number, Product ID and Product Description are: A72; 1IVSP7.5x5; and SofPulse® 7.5” Single Patient Use (1 EA) (5 BX/CA) - PEMF Pulsed Electro Magnetic Field Therapy Device. To order Contact: Academy Medical - Customer service Call: 888.860.0561 Fax: 888.909.7767 Email: govservice@academymedical.net If you need any additional help, please email me directly at: acollier@sofpulseinc.com Sincerely, Alan Collier, CEO","author_name":"Alan Collier","votes":0,"created_at":"2025-07-25T23:41:34Z"}]}],"faq":[{"question":"What is the FSS Contract number or the SIN number so I can look up SofPulse in the MedSurg catalog? Thanks!","answer":"Hi Erick, The SIN number, Product ID and Product Description are: A72; 1IVSP7.5x5; and SofPulse® 7.5” Single Patient Use (1 EA) (5 BX/CA) - PEMF Pulsed Electro Magnetic Field Therapy Device. To order Contact: Academy Medical - Customer service Call: 888.860.0561 Fax: 888.909.7767 Email: govservice@academymedical.net If you need any additional help, please email me directly at: acollier@sofpulseinc.com Sincerely, Alan Collier, CEO"},{"question":"I read the lengthy introduction and promotion of the product.However I really could not find prominent photos and serious explanations of how it looks and works.","answer":"Hi Bruce, Please review our product site at SofPulse.com. Feel free to contact me directly at acollier@sofpulseinc.com with any questions... Thank you for your interest. Sincerely, Alan Collier, CEO"},{"question":"While the obvious benefits of post-operative pain reduction are wonderful, I'm wondering from a business point of view if a much. much larger target market in the future wouldn't be replacing meds as a solution for atherosclerotic inflammation and metaflammation---Jeff Bezos m...","answer":"HI Jerry, Inflammation affects everything. Inflammation can cause cell death and organ failure if not treated and Metabolic inflammation, also known as metainflammation, is a key component in the progression of Non-Alcoholic Fatty Liver Disease (NAFLD) to Nonalcoholic Steatohepatitis (NASH). Because SofPulse® has proven clinical studies that show SofPulse® has effectively reduced inflammation after post-operative procedures, both preclinical and predicate studies have been performed in severa..."},{"question":"Hi Alan, would you please provide some additional details on your \"Robust Patent Portfolio\"? How many are granted, and in which countries, and do you also have ones pending? Do you foresee additional submissions? Thanks. Blessings","answer":"Hi Kim, “Our \"Robust Patent Portfolio”, the SofPulse® patent portfolio, consists of 18 granted patents in the US, Europe and several Asian markets in addition to 10 US trademarks. These patents cover the basic Pulsed Electromagnetic Field (\"PEMF\") technologies as well as use patents describing the use of SofPulse® in various therapeutic applications such as pain, Alzheimer’s, multiple sclerosis and other neurological uses. We have several new patent applications pending submission over the ne..."},{"question":"But how does it work exactly? What method, applied to skin, how and where? Exact details that make it work and how its effective. Lots of info, but nothing on actual details give any potential customer or investor why it works, answering this important question may help you ra...","answer":"Hi Ted, Below are our frequently asked questions. If you have any other questions please email me directly at: acollier@sofpulseinc.com Sincerely, Alan Coliier, CEO SofPulse® Frequently Asked Questions: 1. What is SofPulse®? SofPulse® is a unique technology that utilizes targeted pulsed electromagnetic fields (tPEMF) therapy and is cleared by the FDA to treat pain and edema resulting from operative procedures. The SofPulse® device is simple, automated and easy to use. It has a compact design ..."}]}}}